Avita Medical (ASX:AVH) said last week it tapped former Novartis (NYSE:NVS) global biz dev & licensing chief scientific officer Dr. Michael Perry as its new chief executive officer, replacing resigning CEO Adam Kelliher. Dr. Perry served as a non-exec director of Avita since Feb 2013, according to the company, and held positions with Novartis including chief scientific […]
TransEnterix
Robotic surgery: We’ve got design advice for you
There are a handful of companies in the robotic surgical space. But that is about to change. There is ample evidence that the robotic surgical device market is going to explode in the next 3 to 5 years. We recently spoke with Todd Pope, CEO of TransEnterix who said there is a lot of opportunity […]
TransEnterix inks $17m term loan deal, misses consensus with Q1 earnings
TransEnterix (NYSE:TRXC) said yesterday that it took out a $17 million term loan with an affiliate of Innovatus Capital Partners that it plans to use to get its Senhance robot-assisted surgery platform past the FDA. The Research Triangle Park, N.C.-based company also posted 1st-quarter earnings that missed the consensus forecast by a penny. The 1st $14 million […]
TransEnterix files FDA 510(k) application for Senhance, prices $24.9m round
TransEnterix (NYSE:TRXC) said today that it filed an application with the FDA seeking 510(k) clearance for its Senhance robot-assisted surgery platform and priced a $24.9 million funding round. The application is a huge step forward for the company, CEO Todd Pope told MassDevice.com today in a telephone interview. “The most important milestone that we’ve hit now is […]
Surgical robots: Hospital CTO talks differentiators in new crop of competitors
For the last 10 years, if anyone mentioned robotic surgery or surgical robots, 95 percent of the time they meant the da Vinci robot from Intuitive Surgical. “That product has been so dominantly successful that almost everybody who talks about it is talking with that as their reference point,” said Roger Smith, chief technology officer […]
TransEnterix adds hernia repair to Senhance robotic surgical platform
TransEnterix (NYSE:TRXC) said today it is looking to expand the use of its Senhance robotic surgical system to include hernia repair surgeries, touting that the system has been used in for the 1st time in such procedures in Germany. Research Triangle Park, N.C.-based Transenterix said that Dr. Dietmar Stephan and Dr. Frank Willeke performed up to 3 hernia surgeries […]
TransEnterix shares dip on Q4, FY2016 earnings miss
Shares in TransEnterix (NYSE:TRXC) dipped today after the robotic surgical device developer missed expectations on Wall Street with its 4th quarter and full fiscal year 2016 earnings report. The Research Triangle Park, N.C.-based company posted losses of $14.4 million, or 12¢ per share, on sales of $53,000 for the 3 months ended Dec. 31, with losses growing […]
TransEnterix shares dip despite 1st sale in Germany
Shares in TransEnterix (NYSE:TRXC) have dipped today despite the robotic surgical maker announcing yesterday that it landed the 1st sale of the system in Germany. The Research Triangle, N.C.-based company sold the 1st Senhance surgical system in the country to St. Marien-Krankenhaus Siegen. The hospital said it will use the device to establish a robotic surgical program […]
TransEnterix touts French debut for Senhance robot-assisted surgery device
TransEnterix (NYSE:TRXC) yesterday touted the 1st clinical use in France of its Senhance robot-assisted surgery platform. The 1st French case, performed by Dr. Celine Chauleur of CHU Saint-Ètienne, was a hysterectomy to treat endometrial cancer with pelvic lymphadenectomy Feb. 7. The patient was discharged less than 24 hours after surgery, Morrisville, N.C.-based TransEnterix said. “I am very pleased […]
11 surgical robotics companies you need to know
Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest surgical robot players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on to find […]
Sofar puts another $5m into TransEnterix
TransEnterix (NYSE:TRXC) said today that Italy’s Sofar SpA agreed to buy a $5 million stake in lieu of a $10 million milestone payment as the duo amended the $100 million deal for Sofar’s Telelap ALF-X robot-assisted surgery device – now known as Senhance. In September 2015, TransEnterix bought the Senhance technology for $25 million up front and about 15.5 […]
